B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Midostaurin

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Midostaurin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
166 shared targets
nintedanib
157 shared targets
lestaurtinib
204 shared targets
kw
174 shared targets
tae
174 shared targets
fedratinib
166 shared targets
r
159 shared targets
dovitinib
131 shared targets
tozasertib
131 shared targets
ruboxistaurin
100 shared targets
Loading evidence profile...

This evidence profile for Midostaurin is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.